Unadjusted model β (95% CI) | Minimally adjusted model β (95% CI) | Fully adjusted model β (95% CI) | |
---|---|---|---|
Per 1 μmol/L increase | −9.2 (−16.4, −2.0)* | −4.5 (− 12.1, 3.0) | −5.6 (− 13.5, 2.3) |
Stratified by sex | |||
Men | −1.6 (− 12.1, 8.8) | 1.2 (− 9.0, 11.4) | 3.3 (− 7.5, 14.0) |
LnBLL (Quartile) | |||
Q1 | Reference | Reference | Reference |
Q2 | −23.1 (−42.3, −3.9) | − 21.6 (− 40.2, − 2.9) | −18.0 (− 37.0, 1.1) |
Q3 | −9.6 (− 28.9, 9.7) | − 6.2 (− 24.9, 12.6) | −5.8 (− 25.2, 13.6) |
Q4 | −8.8 (− 27.8, 10.2) | − 2.8 (− 21.5, 15.8) | 2.7 (− 17.0, 22.4) |
P for trend | 0.635 | 0.850 | 0.534 |
Women | −12.4 (− 23.7, − 1.1)** | −12.6 (− 24.0, − 1.3)** | −18.2 (− 29.9, − 6.4)*** |
LnBLL (Quartile) | |||
Q1 | Reference | Reference | Reference |
Q2 | 15.3 (− 2.4, 33.0) | 14.5 (− 3.0, 32.0) | 13.7 (− 3.7, 31.1) |
Q3 | −2.6 (− 20.4, 15.2) | −3.3 (− 21.0, 14.3) | −9.0 (− 26.9, 8.9) |
Q4 | −6.8 (− 25.4, 11.9) | −7.0 (− 25.8, 11.7) | − 17.3 (− 36.6, 2.0) |
P for trend | 0.441 | 0.415 | 0.099 |